These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17187083)

  • 1. Nonhomogeneous immunostaining of hyaline membranes in different manifestations of diffuse alveolar damage.
    Peres e Serra A; Parra ER; Eher E; Capelozzi VL
    Clinics (Sao Paulo); 2006 Dec; 61(6):497-502. PubMed ID: 17187083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterisation of pulmonary hyaline membrane in various types of interstitial pneumonia.
    Sun AP; Ohtsuki Y; Fujita J; Ishida T; Yoshinouchi T; Kohno N
    Pathology; 2003 Apr; 35(2):120-4. PubMed ID: 12745458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two forms of diffuse alveolar damage in the lungs of patients with acute respiratory distress syndrome.
    Kang D; Nakayama T; Togashi M; Yamamoto M; Takahashi M; Kunugi S; Ishizaki M; Fukuda Y
    Hum Pathol; 2009 Nov; 40(11):1618-27. PubMed ID: 19647854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Stages of Hyaline Membrane Formation Detected in Alveolar Mouths in Diffuse Alveolar-Damage-Associated Diseases: A Detailed Immunohistochemical Study.
    Ohtsuki Y; Fujita J; Yoshinouchi T; Enzan H; Iguchi M; Lee GH; Furihata M
    Int J Surg Pathol; 2015 Oct; 23(7):524-30. PubMed ID: 26183849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse alveolar damage and acute interstitial pneumonitis: histochemical evaluation with lectins and monoclonal antibodies against surfactant apoprotein and collagen type IV.
    Sugiyama K; Kawai T
    Mod Pathol; 1993 May; 6(3):242-8. PubMed ID: 8346171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lung pathology and pathogenesis of severe acute respiratory syndrome: a report of six full autopsies].
    Pei F; Zheng J; Gao ZF; Zhong YF; Fang WG; Gong EC; Zou WZ; Wang SL; Gao DX; Xie ZG; Lu M; Shi XY; Liu CR; Yang JP; Wang YP; Han ZH; Shi XH; Dao WB; Gu J
    Zhonghua Bing Li Xue Za Zhi; 2005 Oct; 34(10):656-60. PubMed ID: 16536279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organizing pneumonia and pulmonary lymphatic architecture in diffuse alveolar damage.
    Mandal RV; Mark EJ; Kradin RL
    Hum Pathol; 2008 Aug; 39(8):1234-8. PubMed ID: 18602671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CA19-9-producing idiopathic pulmonary fibrosis with diffuse alveolar damage and a high titer of KL-6--an autopsy case].
    Shimizu Y; Tanaka Y; Sasaki A; Nemoto T
    Nihon Kokyuki Gakkai Zasshi; 2001 May; 39(5):351-6. PubMed ID: 11510099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity in fibrosing lung diseases: a comparative study of Ki-67 immunoreactivity in diffuse alveolar damage, bronchiolitis obliterans-organizing pneumonia, and usual interstitial pneumonia.
    El-Zammar O; Rosenbaum P; Katzenstein AL
    Hum Pathol; 2009 Aug; 40(8):1182-8. PubMed ID: 19368952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse alveolar damage.
    Poletti V; Casoni GL; Cancellieri A; Piciucchi S; Dubini A; Zompatori M
    Pathologica; 2010 Dec; 102(6):453-63. PubMed ID: 21428112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse alveolar damage of the lungs in forensic autopsies: assessment of histopathological stages and causes of death.
    Nur Urer H; Ersoy G; Yılmazbayhan ED
    ScientificWorldJournal; 2012; 2012():657316. PubMed ID: 23028252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute interstitial pneumonia.
    Bouros D; Nicholson AC; Polychronopoulos V; du Bois RM
    Eur Respir J; 2000 Feb; 15(2):412-8. PubMed ID: 10706513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and safety of open lung biopsy in patients with acute respiratory distress syndrome (ARDS).
    Ortiz G; Garay M; Mendoza D; Cardinal-Fernández P
    Med Intensiva (Engl Ed); 2019 Apr; 43(3):139-146. PubMed ID: 29501285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome.
    Yousem SA; Gibson K; Kaminski N; Oddis CV; Ascherman DP
    Mod Pathol; 2010 Jun; 23(6):874-80. PubMed ID: 20228783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse alveolar lesion in BALB/c mice induced with human reovirus BYD1 strain and its potential relation with SARS.
    He C; Yang Q; Lei M; Pang W; Yang J; Zhu H; Duan Q
    Exp Anim; 2006 Oct; 55(5):439-47. PubMed ID: 17090960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autopsy-proven causes of death in lungs of patients immunocompromised by secondary interstitial pneumonia.
    Terrabuio Junior AA; Parra ER; Farhat C; Capelozzi VL
    Clinics (Sao Paulo); 2007 Feb; 62(1):69-76. PubMed ID: 17334552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial pneumonia and diffuse alveolar damage in domestic animals.
    Carvallo FR; Stevenson VB
    Vet Pathol; 2022 Jul; 59(4):586-601. PubMed ID: 35253541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibrosing process in so-called organized diffuse alveolar damage. An immunohistochemical study of the change from hyaline membrane to membranous fibrosis.
    Kobashi Y; Manabe T
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(1):47-52. PubMed ID: 7679849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage.
    Fukuda Y; Ishizaki M; Masuda Y; Kimura G; Kawanami O; Masugi Y
    Am J Pathol; 1987 Jan; 126(1):171-82. PubMed ID: 3812636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease.
    Sakamoto K; Taniguchi H; Kondoh Y; Ono K; Hasegawa Y; Kitaichi M
    Eur Respir Rev; 2009 Jun; 18(112):129-32. PubMed ID: 20956132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.